Search

Vinh Luong

Examiner (ID: 9155, Phone: (571)272-7109 , Office: P/3656 )

Most Active Art Unit
3656
Art Unit(s)
3502, 3656, 3681, 3508, 2899, 3682, 3622, 3736
Total Applications
3233
Issued Applications
2366
Pending Applications
116
Abandoned Applications
750

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5727457 [patent_doc_number] => 20060058217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Compositions and methods for treatment of ovarian cancer' [patent_app_type] => utility [patent_app_number] => 10/541474 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5749 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058217.pdf [firstpage_image] =>[orig_patent_app_number] => 10541474 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/541474
Compositions and methods for treatment of ovarian cancer Jan 19, 2004 Abandoned
Array ( [id] => 5799424 [patent_doc_number] => 20060034911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'New oral immediated release dosage form' [patent_app_type] => utility [patent_app_number] => 10/537858 [patent_app_country] => US [patent_app_date] => 2003-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4082 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034911.pdf [firstpage_image] =>[orig_patent_app_number] => 10537858 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/537858
New oral immediated release dosage form Dec 7, 2003 Abandoned
Array ( [id] => 5716177 [patent_doc_number] => 20060079540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Pde4 and pde3/4 inhibitors for use in the treatment of cachexia' [patent_app_type] => utility [patent_app_number] => 10/535815 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5580 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079540.pdf [firstpage_image] =>[orig_patent_app_number] => 10535815 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/535815
Pde4 and pde3/4 inhibitors for use in the treatment of cachexia Nov 25, 2003 Abandoned
Array ( [id] => 5649853 [patent_doc_number] => 20060135588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Preventive and/or therapeutic drugs for inflammatory intestinal diseases' [patent_app_type] => utility [patent_app_number] => 10/526943 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5765 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135588.pdf [firstpage_image] =>[orig_patent_app_number] => 10526943 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/526943
Preventive and/or therapeutic drugs for inflammatory intestinal diseases Sep 8, 2003 Abandoned
Array ( [id] => 5875441 [patent_doc_number] => 20060167045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/524865 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9003 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167045.pdf [firstpage_image] =>[orig_patent_app_number] => 10524865 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/524865
Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist Aug 14, 2003 Abandoned
Array ( [id] => 6926631 [patent_doc_number] => 20050239888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Pharmaceutical compositions containing keto-acids for endoperitoneal administration' [patent_app_type] => utility [patent_app_number] => 10/522154 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1733 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239888.pdf [firstpage_image] =>[orig_patent_app_number] => 10522154 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/522154
Pharmaceutical compositions containing keto-acids for endoperitoneal administration Jul 24, 2003 Abandoned
Array ( [id] => 5733614 [patent_doc_number] => 20060258731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Antitumor compound and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 10/522081 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4487 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258731.pdf [firstpage_image] =>[orig_patent_app_number] => 10522081 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/522081
Antitumor compound and therapeutic uses thereof Jul 21, 2003 Abandoned
Array ( [id] => 5794158 [patent_doc_number] => 20060014839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction' [patent_app_type] => utility [patent_app_number] => 10/514681 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18098 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014839.pdf [firstpage_image] =>[orig_patent_app_number] => 10514681 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514681
Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction May 15, 2003 Abandoned
Array ( [id] => 7051362 [patent_doc_number] => 20050187249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Lypohilization product' [patent_app_type] => utility [patent_app_number] => 10/513339 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5003 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187249.pdf [firstpage_image] =>[orig_patent_app_number] => 10513339 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/513339
Lypohilization product May 12, 2003 Abandoned
Array ( [id] => 5721304 [patent_doc_number] => 20060074080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Combination product comprising melagatran and an anti-arrhythmic oxabispidenes' [patent_app_type] => utility [patent_app_number] => 10/513187 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9676 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074080.pdf [firstpage_image] =>[orig_patent_app_number] => 10513187 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/513187
Combination product comprising melagatran and an anti-arrhythmic oxabispidenes May 4, 2003 Abandoned
Array ( [id] => 7145641 [patent_doc_number] => 20050119259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes' [patent_app_type] => utility [patent_app_number] => 10/513190 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12861 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119259.pdf [firstpage_image] =>[orig_patent_app_number] => 10513190 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/513190
Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes May 4, 2003 Abandoned
Array ( [id] => 7040726 [patent_doc_number] => 20050159481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Medicinal composition for improving angiotension-regulating function of blood vessel endothelium' [patent_app_type] => utility [patent_app_number] => 10/511587 [patent_app_country] => US [patent_app_date] => 2003-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3385 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159481.pdf [firstpage_image] =>[orig_patent_app_number] => 10511587 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/511587
Medicinal composition for improving angiotension-regulating function of blood vessel endothelium Apr 17, 2003 Abandoned
Array ( [id] => 7105582 [patent_doc_number] => 20050107470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia' [patent_app_type] => utility [patent_app_number] => 10/510450 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2537 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107470.pdf [firstpage_image] =>[orig_patent_app_number] => 10510450 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/510450
Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia Apr 7, 2003 Abandoned
Array ( [id] => 7070055 [patent_doc_number] => 20050245440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2' [patent_app_type] => utility [patent_app_number] => 10/510214 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9863 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245440.pdf [firstpage_image] =>[orig_patent_app_number] => 10510214 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/510214
Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2 Apr 6, 2003 Abandoned
Array ( [id] => 5189071 [patent_doc_number] => 20070167380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Taste masked compositions of erythromycin a and derivatives thereof' [patent_app_type] => utility [patent_app_number] => 10/509824 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2819 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167380.pdf [firstpage_image] =>[orig_patent_app_number] => 10509824 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/509824
Taste masked compositions of erythromycin a and derivatives thereof Apr 2, 2003 Abandoned
Array ( [id] => 5769497 [patent_doc_number] => 20060020046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies' [patent_app_type] => utility [patent_app_number] => 10/504829 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3595 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20060020046.pdf [firstpage_image] =>[orig_patent_app_number] => 10504829 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/504829
Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies Feb 5, 2003 Abandoned
Array ( [id] => 7180533 [patent_doc_number] => 20050124557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia' [patent_app_type] => utility [patent_app_number] => 10/502355 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16687 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124557.pdf [firstpage_image] =>[orig_patent_app_number] => 10502355 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/502355
Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia Jan 22, 2003 Abandoned
Menu